Capitol Connection

Subscribe to Capitol Connection

Get updates and share your views on recent developments in science and technology policy.

  • October 14, 2014

    One of the most pressing scientific issues facing Congress today is the risk that antibiotic resistance presents to human health. Unlike other political-scientific hot potatoes, such as global warming, the House and Senate crossed the aisle to pass a bipartisan bill to speed new antibiotics to market, and are working on a new bill to make FDA approval even easier. »

  • October 6, 2014

    A recent study finds a significant logjam in the development of new drugs at the discovery and early preclinical phases. Could the creation of an open-source translational research database help solve the problem? »

  • July 17, 2014

    The National Children’s Study (NCS), which aims to follow the health of 100,000 babies until they turn 21, is now on hold following an assessment by the Institute of Medicine (IOM) and National Research Council (NRC). The IOM/NRC report notes several flaws with the study’s design and oversight. In response, National Institutes of Health (NIH) Director Francis Collins decided to halt the NCS until possible fixes can be evaluated.

     »

  • July 8, 2014

    Researchers have long used scientific specimen collections as sources of data on an animal's environment, diet and its very DNA. However, a debate has emerged among biologists over the ethics of collecting specimens of rare species whose numbers are dwindling. Some biologists argue that specimen collection provides them with critical information about a species. In addition, their collection counts for a small number of species compared with those that die from other man-made threats, such as habitat destruction. »

  • July 1, 2014

    The National Institutes of Health (NIH) and National Science Foundation (NSF) are teaming up to help researchers commercialize new biomedical discoveries. Researchers who are part of the new I-Corps at NIH pilot program will participate in a nine-week boot camp where they will meet with business experts and potential customers. I-Corps at NIH is the newest outgrowth of the NSF’s Innovation Corps (I-Corps) private-public partnership program, which helps commercialize selected federally funded research projects. »